Rituximab in treatment of a patient with granulomatosis with polyangitis - a case report
Journal
Македонски медицински преглед = Macedonian medical review
Date Issued
2023-01
Author(s)
Guchev, Filip
Antova, Dubravka
Karadzova Stojanovska, Anzhelika
Vidinikj, Sonja
Vasilevska, Ana
Vejseli, Ron
Abstract
ANCA-associated vasculitis (AAV) is a necrotizing vasculitis with few or no immune deposits that can affect predominantly small vessels. It can affect vessels in every organ and tissue of the body; the clinical manifestations of the disease are extremely variable. B-cells are of major importance in the disease pathogenesis as precursors of ANCA-producing plasma cells and, possibly, also as antigen-presenting and cytokineproducing cells. Therefore, rituximab, a monoclonal antibody drug causing partial B-cell depletion, has emerged as a powerful option in the treatment of AAV such as granulomatosis with polyangiitis. We present the case of a 25-year-old female diagnosed with granulomatosis with polyangiitis and treated with rituximab and high-dose corticosteroids.
File(s)![Thumbnail Image]()
Loading...
Name
MMP 78(1) 2024, 51-53.pdf
Size
4.29 MB
Format
Adobe PDF
Checksum
(MD5):559669bf1e526839b127e282a8b38b09